Controlled Dual Activation of Rhenium(I) Photosensitizers and Profluorophores/Prodrugs via a Dissociative Bioorthogonal Tetrazine–Isonitrile Reaction
Open Access
- 21 October 2025
- journal article
- Published by Wiley in Angewandte Chemie
- Vol. 137 (50)
Abstract
Strategies for prodrug activation have been developed to enhance treatment efficacy, with bioorthogonal dissociation reactions emerging as a promising approach due to their remarkable specificity. In this work, we designed three rhenium(I) polypyridine complexes featuring a tetrazylmethyl (TzMe) group capable of bioorthogonal activation by 3‐isocyanopropyl (ICPr) or 3‐isocyanopropyl‐1‐carbamoyl (ICPrc) derivatives. This design serves as a dual‐release platform, which liberates rhenium(I) 3‐hydroxypyridine complexes and functional payloads from rhenium(I) TzMe complexes and ICPr/ICPrc‐caged compounds, respectively. Upon incubation with an ICPrc derivative, the TzMe complexes exhibited strong emission in acidic buffers, attributed to the predominant existence of the resulting rhenium(I) 3‐hydroxypyridine complexes in their protonated form. Confocal imaging of live cells incubated with a TzMe complex and ICPr‐caged fluorescein unveiled intense intracellular emission in distinct channels. Importantly, the therapeutic potential of this approach was underscored by the treatment of cells with a TzMe complex and ICPrc‐caged doxorubicin. The anticancer effect was amplified through the synergy between singlet oxygen ( 1 O 2 ) photosensitization and prodrug activation, effectively combining photodynamic therapy with chemotherapy. The more pronounced 1 O 2 generation of the 3‐hydroxypyridine complexes in acidic media and their specific accumulation within the acidic lysosomes of cancer cells highlight the potential of bioorthogonal prodrug activation for effective cancer‐targeted therapy.Keywords
This publication has 37 references indexed in Scilit:
- A Concerted Enzymatic and Bioorthogonal Approach for Extra‐ and Intracellular Activation of Environment‐Sensitive Ruthenium(II)‐Based Imaging Probes and PhotosensitizersAngewandte Chemie, 2023
- A tetrazine-responsive isonitrile-caged photosensitiser for site-specific photodynamic therapyJournal of Controlled Release, 2022
- Phosphorogenic Iridium(III) bis‐Tetrazine Complexes for Bioorthogonal Peptide Stapling, Bioimaging, Photocytotoxic Applications, and the Construction of Nanosized HydrogelsAngewandte Chemie, 2022
- Utilization of Rhenium(I) Polypyridine Complexes Featuring a Dinitrophenylsulfonamide Moiety as Biothiol‐Selective Phosphorogenic Bioimaging Reagents and Photocytotoxic AgentsEuropean Journal of Inorganic Chemistry, 2021
- Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategiesJournal of Controlled Release, 2020
- Installing an additional emission quenching pathway in the design of iridium(III)-based phosphorogenic biomaterials for bioorthogonal labelling and imagingBiomaterials, 2016
- Wahrnehmung der chemischen Prozesse in einzelnen Organellen mit niedermolekularen FluoreszenzsondenAngewandte Chemie, 2016
- Nanomedicine and tumor heterogeneity: Concept and complex realityNano Today, 2016
- Prodrug-based intracellular delivery of anticancer agentsAdvanced Drug Delivery Reviews, 2011
- Prodrug Strategies in Anticancer ChemotherapyChemMedChem, 2008